Kilitch Drugs (India) Limited (BOM:524500)
India · Delayed Price · Currency is INR 317.30
-1.90 (-0.60%)
At close: Jan 22, 2026
Kilitch Drugs (India) Market Cap
Kilitch Drugs (India) has a market cap or net worth of 5.1 billion as of January 23, 2026. Its market cap has decreased by -7.61% in one year.
Market Cap
5.10B
Enterprise Value
5.05B
Revenue
2.09B
Ranking
n/a
PE Ratio
18.42
Stock Price
317.30
Market Cap Chart
Since March 5, 2002, Kilitch Drugs (India)'s market cap has increased from 14.33M to 5.10B, an increase of 35,504.01%. That is a compound annual growth rate of 27.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 5.05B | -10.49% |
| Dec 31, 2025 | 5.64B | 7.84% |
| Dec 31, 2024 | 5.23B | -12.48% |
| Dec 29, 2023 | 5.98B | 145.95% |
| Dec 30, 2022 | 2.43B | -37.79% |
| Dec 31, 2021 | 3.91B | 162.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anuh Pharma | 7.31B |
| Fredun Pharmaceuticals | 7.10B |
| Accent Microcell | 6.77B |
| Kopran | 6.55B |
| Wanbury | 6.18B |
| Jenburkt Pharmaceuticals | 4.68B |
| Sudarshan Pharma Industries | 4.67B |
| Medicamen Biotech | 4.57B |